Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Lung Tumor Ablation Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Lung Tumor Ablation Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 136 Pages
Report ld: 5350293
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Lung Tumor Ablation Market Size(US$)
CAGR 2025-2031
9.3%
Market Size,2031
USD 4,134
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 2,425 million
Market Forecast in 2031(Value)
US$ 4,134 million
CAGR
9.3%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Lung Tumor Ablation market is projected to grow from US$ 2237 million in 2024 to US$ 4134 million by 2031, at a CAGR of 9.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Lung tumor ablation is a minimally-invasive image-guided procedure (MIIP) to destroy the cancer without having to cut it out. Ablation can be an effective treatment option for patients who wish to avoid surgery or for whom surgery is not an option.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Lung Tumor Ablation market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Medtronic
- Olympus
- LungCare
- Broncus
- Intuitive Surgica
- Auris Health
- Angiodynamics
- Boston Scientific
- Smith and Nephew
- VISON Medical
- Nanjing MICRO-TECH
- TIPC
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Radiofrequency Ablation (RFA)
- Microwave Ablation (MWA)
- Cold Ablation
- Others
Segment by Application
- Hospitals
- Ambulatory Surgical Centers
CHAPTER OUTLINE
Chapter 1: Defines the Lung Tumor Ablation study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; top-tier players 2024 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Lung Tumor Ablation: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Lung Tumor Ablation Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Radiofrequency Ablation (RFA)
1.2.3 Microwave Ablation (MWA)
1.2.4 Cold Ablation
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Lung Tumor Ablation Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Lung Tumor Ablation Revenue Estimates and Forecasts 2020-2031
2.2 Global Lung Tumor Ablation Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Lung Tumor Ablation Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Lung Tumor Ablation Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Radiofrequency Ablation (RFA) Market Size by Players
3.3.2 Microwave Ablation (MWA) Market Size by Players
3.3.3 Cold Ablation Market Size by Players
3.3.4 Others Market Size by Players
3.4 Global Lung Tumor Ablation Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Lung Tumor Ablation Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Lung Tumor Ablation Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Lung Tumor Ablation Market Size by Type (2020-2031)
6.4 North America Lung Tumor Ablation Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Lung Tumor Ablation Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Lung Tumor Ablation Market Size by Type (2020-2031)
7.4 Europe Lung Tumor Ablation Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Lung Tumor Ablation Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Lung Tumor Ablation Market Size by Type (2020-2031)
8.4 Asia-Pacific Lung Tumor Ablation Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Lung Tumor Ablation Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Lung Tumor Ablation Market Size by Type (2020-2031)
9.4 Central and South America Lung Tumor Ablation Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Lung Tumor Ablation Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Lung Tumor Ablation Market Size by Type (2020-2031)
10.4 Middle East and Africa Lung Tumor Ablation Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Lung Tumor Ablation Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Medtronic
11.1.1 Medtronic Corporation Information
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Lung Tumor Ablation Product Features and Attributes
11.1.4 Medtronic Lung Tumor Ablation Revenue and Gross Margin (2020-2025)
11.1.5 Medtronic Lung Tumor Ablation Revenue by Product in 2024
11.1.6 Medtronic Lung Tumor Ablation Revenue by Application in 2024
11.1.7 Medtronic Lung Tumor Ablation Revenue by Geographic Area in 2024
11.1.8 Medtronic Lung Tumor Ablation SWOT Analysis
11.1.9 Medtronic Recent Developments
11.2 Olympus
11.2.1 Olympus Corporation Information
11.2.2 Olympus Business Overview
11.2.3 Olympus Lung Tumor Ablation Product Features and Attributes
11.2.4 Olympus Lung Tumor Ablation Revenue and Gross Margin (2020-2025)
11.2.5 Olympus Lung Tumor Ablation Revenue by Product in 2024
11.2.6 Olympus Lung Tumor Ablation Revenue by Application in 2024
11.2.7 Olympus Lung Tumor Ablation Revenue by Geographic Area in 2024
11.2.8 Olympus Lung Tumor Ablation SWOT Analysis
11.2.9 Olympus Recent Developments
11.3 LungCare
11.3.1 LungCare Corporation Information
11.3.2 LungCare Business Overview
11.3.3 LungCare Lung Tumor Ablation Product Features and Attributes
11.3.4 LungCare Lung Tumor Ablation Revenue and Gross Margin (2020-2025)
11.3.5 LungCare Lung Tumor Ablation Revenue by Product in 2024
11.3.6 LungCare Lung Tumor Ablation Revenue by Application in 2024
11.3.7 LungCare Lung Tumor Ablation Revenue by Geographic Area in 2024
11.3.8 LungCare Lung Tumor Ablation SWOT Analysis
11.3.9 LungCare Recent Developments
11.4 Broncus
11.4.1 Broncus Corporation Information
11.4.2 Broncus Business Overview
11.4.3 Broncus Lung Tumor Ablation Product Features and Attributes
11.4.4 Broncus Lung Tumor Ablation Revenue and Gross Margin (2020-2025)
11.4.5 Broncus Lung Tumor Ablation Revenue by Product in 2024
11.4.6 Broncus Lung Tumor Ablation Revenue by Application in 2024
11.4.7 Broncus Lung Tumor Ablation Revenue by Geographic Area in 2024
11.4.8 Broncus Lung Tumor Ablation SWOT Analysis
11.4.9 Broncus Recent Developments
11.5 Intuitive Surgica
11.5.1 Intuitive Surgica Corporation Information
11.5.2 Intuitive Surgica Business Overview
11.5.3 Intuitive Surgica Lung Tumor Ablation Product Features and Attributes
11.5.4 Intuitive Surgica Lung Tumor Ablation Revenue and Gross Margin (2020-2025)
11.5.5 Intuitive Surgica Lung Tumor Ablation Revenue by Product in 2024
11.5.6 Intuitive Surgica Lung Tumor Ablation Revenue by Application in 2024
11.5.7 Intuitive Surgica Lung Tumor Ablation Revenue by Geographic Area in 2024
11.5.8 Intuitive Surgica Lung Tumor Ablation SWOT Analysis
11.5.9 Intuitive Surgica Recent Developments
11.6 Auris Health
11.6.1 Auris Health Corporation Information
11.6.2 Auris Health Business Overview
11.6.3 Auris Health Lung Tumor Ablation Product Features and Attributes
11.6.4 Auris Health Lung Tumor Ablation Revenue and Gross Margin (2020-2025)
11.6.5 Auris Health Recent Developments
11.7 Angiodynamics
11.7.1 Angiodynamics Corporation Information
11.7.2 Angiodynamics Business Overview
11.7.3 Angiodynamics Lung Tumor Ablation Product Features and Attributes
11.7.4 Angiodynamics Lung Tumor Ablation Revenue and Gross Margin (2020-2025)
11.7.5 Angiodynamics Recent Developments
11.8 Boston Scientific
11.8.1 Boston Scientific Corporation Information
11.8.2 Boston Scientific Business Overview
11.8.3 Boston Scientific Lung Tumor Ablation Product Features and Attributes
11.8.4 Boston Scientific Lung Tumor Ablation Revenue and Gross Margin (2020-2025)
11.8.5 Boston Scientific Recent Developments
11.9 Smith and Nephew
11.9.1 Smith and Nephew Corporation Information
11.9.2 Smith and Nephew Business Overview
11.9.3 Smith and Nephew Lung Tumor Ablation Product Features and Attributes
11.9.4 Smith and Nephew Lung Tumor Ablation Revenue and Gross Margin (2020-2025)
11.9.5 Smith and Nephew Recent Developments
11.10 VISON Medical
11.10.1 VISON Medical Corporation Information
11.10.2 VISON Medical Business Overview
11.10.3 VISON Medical Lung Tumor Ablation Product Features and Attributes
11.10.4 VISON Medical Lung Tumor Ablation Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Nanjing MICRO-TECH
11.11.1 Nanjing MICRO-TECH Corporation Information
11.11.2 Nanjing MICRO-TECH Business Overview
11.11.3 Nanjing MICRO-TECH Lung Tumor Ablation Product Features and Attributes
11.11.4 Nanjing MICRO-TECH Lung Tumor Ablation Revenue and Gross Margin (2020-2025)
11.11.5 Nanjing MICRO-TECH Recent Developments
11.12 TIPC
11.12.1 TIPC Corporation Information
11.12.2 TIPC Business Overview
11.12.3 TIPC Lung Tumor Ablation Product Features and Attributes
11.12.4 TIPC Lung Tumor Ablation Revenue and Gross Margin (2020-2025)
11.12.5 TIPC Recent Developments
12 Lung Tumor AblationIndustry Chain Analysis
12.1 Lung Tumor Ablation Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Lung Tumor Ablation Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Lung Tumor Ablation Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Lung Tumor Ablation Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Lung Tumor Ablation Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Lung Tumor Ablation Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Lung Tumor Ablation Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Lung Tumor Ablation Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Lung Tumor Ablation Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Lung Tumor Ablation Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Lung Tumor Ablation by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Tumor Ablation as of 2024)
Table 11. Global Lung Tumor Ablation Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Lung Tumor Ablation Companies Headquarters
Table 13. Global Lung Tumor Ablation Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Lung Tumor Ablation Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Lung Tumor Ablation Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Lung Tumor Ablation Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Lung Tumor Ablation Revenue by Application (2026-2031) & (US$ Million)
Table 21. Lung Tumor Ablation High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Lung Tumor Ablation Growth Accelerators and Market Barriers
Table 25. North America Lung Tumor Ablation Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Lung Tumor Ablation Growth Accelerators and Market Barriers
Table 27. Europe Lung Tumor Ablation Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Lung Tumor Ablation Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Lung Tumor Ablation Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Lung Tumor Ablation Investment Opportunities and Key Challenges
Table 31. Central and South America Lung Tumor Ablation Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Lung Tumor Ablation Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Lung Tumor Ablation Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Medtronic Corporation Information
Table 35. Medtronic Description and Major Businesses
Table 36. Medtronic Product Features and Attributes
Table 37. Medtronic Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Medtronic Revenue Proportion by Product in 2024
Table 39. Medtronic Revenue Proportion by Application in 2024
Table 40. Medtronic Revenue Proportion by Geographic Area in 2024
Table 41. Medtronic Lung Tumor Ablation SWOT Analysis
Table 42. Medtronic Recent Developments
Table 43. Olympus Corporation Information
Table 44. Olympus Description and Major Businesses
Table 45. Olympus Product Features and Attributes
Table 46. Olympus Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Olympus Revenue Proportion by Product in 2024
Table 48. Olympus Revenue Proportion by Application in 2024
Table 49. Olympus Revenue Proportion by Geographic Area in 2024
Table 50. Olympus Lung Tumor Ablation SWOT Analysis
Table 51. Olympus Recent Developments
Table 52. LungCare Corporation Information
Table 53. LungCare Description and Major Businesses
Table 54. LungCare Product Features and Attributes
Table 55. LungCare Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. LungCare Revenue Proportion by Product in 2024
Table 57. LungCare Revenue Proportion by Application in 2024
Table 58. LungCare Revenue Proportion by Geographic Area in 2024
Table 59. LungCare Lung Tumor Ablation SWOT Analysis
Table 60. LungCare Recent Developments
Table 61. Broncus Corporation Information
Table 62. Broncus Description and Major Businesses
Table 63. Broncus Product Features and Attributes
Table 64. Broncus Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Broncus Revenue Proportion by Product in 2024
Table 66. Broncus Revenue Proportion by Application in 2024
Table 67. Broncus Revenue Proportion by Geographic Area in 2024
Table 68. Broncus Lung Tumor Ablation SWOT Analysis
Table 69. Broncus Recent Developments
Table 70. Intuitive Surgica Corporation Information
Table 71. Intuitive Surgica Description and Major Businesses
Table 72. Intuitive Surgica Product Features and Attributes
Table 73. Intuitive Surgica Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Intuitive Surgica Revenue Proportion by Product in 2024
Table 75. Intuitive Surgica Revenue Proportion by Application in 2024
Table 76. Intuitive Surgica Revenue Proportion by Geographic Area in 2024
Table 77. Intuitive Surgica Lung Tumor Ablation SWOT Analysis
Table 78. Intuitive Surgica Recent Developments
Table 79. Auris Health Corporation Information
Table 80. Auris Health Description and Major Businesses
Table 81. Auris Health Product Features and Attributes
Table 82. Auris Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Auris Health Recent Developments
Table 84. Angiodynamics Corporation Information
Table 85. Angiodynamics Description and Major Businesses
Table 86. Angiodynamics Product Features and Attributes
Table 87. Angiodynamics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Angiodynamics Recent Developments
Table 89. Boston Scientific Corporation Information
Table 90. Boston Scientific Description and Major Businesses
Table 91. Boston Scientific Product Features and Attributes
Table 92. Boston Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Boston Scientific Recent Developments
Table 94. Smith and Nephew Corporation Information
Table 95. Smith and Nephew Description and Major Businesses
Table 96. Smith and Nephew Product Features and Attributes
Table 97. Smith and Nephew Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Smith and Nephew Recent Developments
Table 99. VISON Medical Corporation Information
Table 100. VISON Medical Description and Major Businesses
Table 101. VISON Medical Product Features and Attributes
Table 102. VISON Medical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. VISON Medical Recent Developments
Table 104. Nanjing MICRO-TECH Corporation Information
Table 105. Nanjing MICRO-TECH Description and Major Businesses
Table 106. Nanjing MICRO-TECH Product Features and Attributes
Table 107. Nanjing MICRO-TECH Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Nanjing MICRO-TECH Recent Developments
Table 109. TIPC Corporation Information
Table 110. TIPC Description and Major Businesses
Table 111. TIPC Product Features and Attributes
Table 112. TIPC Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. TIPC Recent Developments
Table 114. Raw Materials Key Suppliers
Table 115. Distributors List
Table 116. Market Trends and Market Evolution
Table 117. Market Drivers and Opportunities
Table 118. Market Challenges, Risks, and Restraints
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Lung Tumor Ablation Product Picture
Figure 2. Global Lung Tumor Ablation Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Radiofrequency Ablation (RFA) Product Picture
Figure 4. Microwave Ablation (MWA) Product Picture
Figure 5. Cold Ablation Product Picture
Figure 6. Others Product Picture
Figure 7. Global Lung Tumor Ablation Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Hospitals
Figure 9. Ambulatory Surgical Centers
Figure 10. Lung Tumor Ablation Report Years Considered
Figure 11. Global Lung Tumor Ablation Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Lung Tumor Ablation Revenue (2020-2031) & (US$ Million)
Figure 13. Global Lung Tumor Ablation Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Lung Tumor Ablation Revenue Market Share by Region (2020-2031)
Figure 15. Global Lung Tumor Ablation Revenue Market Share Ranking (2024)
Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 17. Radiofrequency Ablation (RFA) Revenue Market Share by Player in 2024
Figure 18. Microwave Ablation (MWA) Revenue Market Share by Player in 2024
Figure 19. Cold Ablation Revenue Market Share by Player in 2024
Figure 20. Others Revenue Market Share by Player in 2024
Figure 21. Global Lung Tumor Ablation Revenue Market Share by Type (2020-2031)
Figure 22. Global Lung Tumor Ablation Revenue Market Share by Application (2020-2031)
Figure 23. North America Lung Tumor Ablation Revenue YoY (2020-2031) & (US$ Million)
Figure 24. North America Top 5 Players Lung Tumor Ablation Revenue (US$ Million) in 2024
Figure 25. North America Lung Tumor Ablation Revenue (US$ Million) by Type (2020 - 2031)
Figure 26. North America Lung Tumor Ablation Revenue (US$ Million) by Application (2020-2031)
Figure 27. US Lung Tumor Ablation Revenue (2020-2031) & (US$ Million)
Figure 28. Canada Lung Tumor Ablation Revenue (2020-2031) & (US$ Million)
Figure 29. Mexico Lung Tumor Ablation Revenue (2020-2031) & (US$ Million)
Figure 30. Europe Lung Tumor Ablation Revenue YoY (2020-2031) & (US$ Million)
Figure 31. Europe Top 5 Players Lung Tumor Ablation Revenue (US$ Million) in 2024
Figure 32. Europe Lung Tumor Ablation Revenue (US$ Million) by Type (2020-2031)
Figure 33. Europe Lung Tumor Ablation Revenue (US$ Million) by Application (2020-2031)
Figure 34. Germany Lung Tumor Ablation Revenue (2020-2031) & (US$ Million)
Figure 35. France Lung Tumor Ablation Revenue (2020-2031) & (US$ Million)
Figure 36. U.K. Lung Tumor Ablation Revenue (2020-2031) & (US$ Million)
Figure 37. Italy Lung Tumor Ablation Revenue (2020-2031) & (US$ Million)
Figure 38. Russia Lung Tumor Ablation Revenue (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Lung Tumor Ablation Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Top 8 Players Lung Tumor Ablation Revenue (US$ Million) in 2024
Figure 41. Asia-Pacific Lung Tumor Ablation Revenue (US$ Million) by Type (2020-2031)
Figure 42. Asia-Pacific Lung Tumor Ablation Revenue (US$ Million) by Application (2020-2031)
Figure 43. Indonesia Lung Tumor Ablation Revenue (2020-2031) & (US$ Million)
Figure 44. Japan Lung Tumor Ablation Revenue (2020-2031) & (US$ Million)
Figure 45. South Korea Lung Tumor Ablation Revenue (2020-2031) & (US$ Million)
Figure 46. Australia Lung Tumor Ablation Revenue (2020-2031) & (US$ Million)
Figure 47. India Lung Tumor Ablation Revenue (2020-2031) & (US$ Million)
Figure 48. Indonesia Lung Tumor Ablation Revenue (2020-2031) & (US$ Million)
Figure 49. Vietnam Lung Tumor Ablation Revenue (2020-2031) & (US$ Million)
Figure 50. Malaysia Lung Tumor Ablation Revenue (2020-2031) & (US$ Million)
Figure 51. Philippines Lung Tumor Ablation Revenue (2020-2031) & (US$ Million)
Figure 52. Singapore Lung Tumor Ablation Revenue (2020-2031) & (US$ Million)
Figure 53. Central and South America Lung Tumor Ablation Revenue YoY (2020-2031) & (US$ Million)
Figure 54. Central and South America Top 5 Players Lung Tumor Ablation Revenue (US$ Million) in 2024
Figure 55. Central and South America Lung Tumor Ablation Revenue (US$ Million) by Type (2020-2031)
Figure 56. Central and South America Lung Tumor Ablation Revenue (US$ Million) by Application (2020-2031)
Figure 57. Brazil Lung Tumor Ablation Revenue (2020-2025) & (US$ Million)
Figure 58. Argentina Lung Tumor Ablation Revenue (2020-2025) & (US$ Million)
Figure 59. Middle East and Africa Lung Tumor Ablation Revenue YoY (2020-2031) & (US$ Million)
Figure 60. Middle East and Africa Top 5 Players Lung Tumor Ablation Revenue (US$ Million) in 2024
Figure 61. South America Lung Tumor Ablation Revenue (US$ Million) by Type (2020-2031)
Figure 62. Middle East and Africa Lung Tumor Ablation Revenue (US$ Million) by Application (2020-2031)
Figure 63. GCC Countries Lung Tumor Ablation Revenue (2020-2025) & (US$ Million)
Figure 64. Israel Lung Tumor Ablation Revenue (2020-2025) & (US$ Million)
Figure 65. Egypt Lung Tumor Ablation Revenue (2020-2025) & (US$ Million)
Figure 66. South Africa Lung Tumor Ablation Revenue (2020-2025) & (US$ Million)
Figure 67. Lung Tumor Ablation Industry Chain Mapping
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Lung Tumor Ablation in 2031?
The global market size of Lung Tumor Ablation in 2031 was 4134 Million USD.
What was the global market size of Lung Tumor Ablation in 2025?
What is the annual compound growth rate of the global Lung Tumor Ablation market size from 2025 to 2031?
Which companies rank high in the global Lung Tumor Ablation market?
Which region is expected to have the highest market share?
Related Reports
Lung Tumor Ablation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Lung Tumor Ablation was estimated to be worth US$ 2425 million in 2025 and is projected to reach US$ 4480 million, growing at a CAGR of 9.3% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 118
USD 3950.00
(Single User License)
Global Lung Tumor Ablation Market Research Report 2026
The global Lung Tumor Ablation market was valued at US$ 2425 million in 2025 and is anticipated to reach US$ 4480 million by 2032, at a CAGR of 9.3% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 117
USD 2900.00
(Single User License)
Global Lung Tumor Ablation Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Lung Tumor Ablation market size was US$ 2237 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 94
USD 4250.00
(Single User License)
Lung Tumor Ablation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Lung Tumor Ablation was estimated to be worth US$ 2237 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 117
USD 3950.00
(Single User License)
Global Lung Tumor Ablation Market Research Report 2025
The global market for Lung Tumor Ablation was valued at US$ 2237 million in the year 2024 and is projected to reach a revised size of US$ 4134 million by 2031, growing at a CAGR of 9.3% during the forecast period.
Published Date: 2025-01-13
Pages: 90
USD 2900.00
(Single User License)
Global Lung Tumor Ablation Market Insights, Forecast to 2030
Lung tumor ablation is a minimally-invasive image-guided procedure (MIIP) to destroy the cancer without having to cut it out. Ablation can be an effective treatment option for patients who wish to avoid surgery or for whom surgery is not an option.
Published Date: 2024-04-15
Pages: 107
USD 4900.00
(Single User License)
Global Lung Tumor Ablation Market Research Report 2024
Lung tumor ablation is a minimally-invasive image-guided procedure (MIIP) to destroy the cancer without having to cut it out. Ablation can be an effective treatment option for patients who wish to avoid surgery or for whom surgery is not an option.
Published Date: 2024-01-18
Pages: 86
USD 2900.00
(Single User License)
Lung Tumor Ablation - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Lung Tumor Ablation was estimated to be worth US$ 2425 million in 2025 and is projected to reach US$ 4480 million, growing at a CAGR of 9.3% from 2026 to 2032.
Published: 2026-06-16
Pages: 118
USD 3950.00 (Single User License)Global Lung Tumor Ablation Market Research Report 2026
The global Lung Tumor Ablation market was valued at US$ 2425 million in 2025 and is anticipated to reach US$ 4480 million by 2032, at a CAGR of 9.3% from 2026 to 2032.
Published: 2026-04-17
Pages: 117
USD 2900.00 (Single User License)Global Lung Tumor Ablation Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Lung Tumor Ablation market size was US$ 2237 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 94
USD 4250.00 (Single User License)Lung Tumor Ablation- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Lung Tumor Ablation was estimated to be worth US$ 2237 million in 2024 and is forecast to a readjusted size of US$ 4134 million by 2031 with a CAGR of 9.3% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 117
USD 3950.00 (Single User License)Global Lung Tumor Ablation Market Research Report 2025
The global market for Lung Tumor Ablation was valued at US$ 2237 million in the year 2024 and is projected to reach a revised size of US$ 4134 million by 2031, growing at a CAGR of 9.3% during the forecast period.
Published: 2025-01-13
Pages: 90
USD 2900.00 (Single User License)Global Lung Tumor Ablation Market Insights, Forecast to 2030
Lung tumor ablation is a minimally-invasive image-guided procedure (MIIP) to destroy the cancer without having to cut it out. Ablation can be an effective treatment option for patients who wish to avoid surgery or for whom surgery is not an option.
Published: 2024-04-15
Pages: 107
USD 4900.00 (Single User License)Global Lung Tumor Ablation Market Research Report 2024
Lung tumor ablation is a minimally-invasive image-guided procedure (MIIP) to destroy the cancer without having to cut it out. Ablation can be an effective treatment option for patients who wish to avoid surgery or for whom surgery is not an option.
Published: 2024-01-18
Pages: 86
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now